|
|
1. Committee on Opportunities for U.S.-Russian Collaboration in Combating Radiological Terrorism. 2007. U.S.-Russian Collaboration in Combating Radiological Terrorism. Washington, D.C.: National Academies Press. Available online at www.nap.edu/catalog.php?record_id=11801. Members of the authoring committee included John F. Ahearne (chair), director, Ethics Program, Sigma Xi, The Scientific Research Society; Laurin Dodd, managing director, Chernobyl Shelter Implementation Program (SIP), Project Management Unit, Bechtel International Systems, Inc.; Siegfried S. Hecker, director emeritus, Los Alamos National Laboratory, and visiting professor, Center for International Security and Cooperation, Stanford University; Darleane C. Hoffman, professor of the Graduate School, Department of Chemistry, University of California, Berkeley, and faculty senior scientist, Nuclear Science Division, Lawrence Berkeley National Laboratory; Roger Kasperson, research professor, George Perkins Marsh Institute, Clark University; and Leroy E. Leonard (consultant to the committee), project leader, Off-Site Source Recovery Project, Los Alamos National Laboratory.
|
|
|
2. Category 1 sources “if not safely managed or securely protected would be likely to cause permanent injury to a person who handled [them], or were otherwise in contact with [them], for more than a few minutes. It would probably be fatal to be close to this amount of unshielded material for a period of a few minutes to an hour.” These sources are typically used in practices such as radioisotope thermoelectric generators, irradiators, and radiation teletherapy.
Category 2 sources, “if not safely managed or securely protected, could cause permanent injury to a person who handled [them], or were otherwise in contact with [them], for a short time (minutes to hours). It could possibly be fatal to be close to this amount of unshielded radioactive material for a period of hours to days.” These sources are typically used in practices such as industrial gamma radiography, high dose rate brachytherapy, and medium dose rate brachytherapy.
|